P53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel

被引：0
|
作者：
Yumuk, R
Turhal, N
Ahiskali, R
Gumus, M
Hatabay, N
Turken, O
Ozkan, A
Salepci, T
Aliustaoglu, M
机构：
[1] Marmara Univ Hosp, Div Med Oncol, Istanbul, Turkey
[2] Marmara Univ Hosp, Dept Pathol, Istanbul, Turkey
[3] Dr Lutfi Kirdar Res & Training Hosp, Oncol Unit, Istanbul, Turkey
[4] SSK Sureyyapasa Chest & Cardiovasc Dis Hosp, Oncol Unit, Istanbul, Turkey
[5] Gulhane Mil Med Acad, Div Med Oncol, Istanbul, Turkey
[6] Haydarpasa Numune Res & Training Hosp, Oncol Unit, Istanbul, Turkey
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [21] HER-2/NEU and ERCC1 in advanced non-small cell lung cancer
    Yoo, J.
    HISTOPATHOLOGY, 2010, 57 : 220 - 220
  • [22] Increasing P53 Protein Sensitizes Non-Small Cell Lung Cancer to Paclitaxel and Cisplatin In Vitro
    Guntur, Vamsi P.
    Waldrep, J. Clifford
    Guo, Jennifer J.
    Selting, Kim
    Dhand, Rajiv
    ANTICANCER RESEARCH, 2010, 30 (09) : 3557 - 3564
  • [23] Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
    Li, Jian
    Chen, Ping
    Dai, Chun-Hua
    Li, Xiao-Qin
    Bao, Quan-Lei
    ONCOLOGY, 2009, 76 (05) : 355 - 362
  • [24] HER2: defining a Neu target in non-small-cell lung cancer
    Ekman, S.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 353 - 355
  • [25] The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients
    Kim, YC
    Park, KO
    Kern, JA
    Park, CS
    Lim, SC
    Jang, AS
    Yang, JB
    LUNG CANCER, 1998, 22 (03) : 181 - 190
  • [26] Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines
    Duarte, Mariana Lemos
    de Moraes, Emanuela
    Pontes, Elizangela
    Schluckebier, Luciene
    de Moraes, Joyce Luana
    Hainaut, Pierre
    Ferreira, Carlos Gil
    CANCER LETTERS, 2009, 279 (01) : 57 - 64
  • [27] p53 mutations in non-small cell lung cancer in Poland
    Niklinski, J
    Rusin, M
    Chyczewski, L
    Sipowicz, M
    Shiao, YE
    Niklinska, WE
    Laudanski, J
    Furman, M
    Chorazy, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S30 - S30
  • [28] Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
    Cheng-long Huang
    Toshihiko Taki
    Masashi Adachi
    Takaaki Konishi
    Masahiko Higashiyama
    Masayuki Miyake
    Oncogene, 1998, 16 : 2469 - 2477
  • [29] Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
    Huang, C
    Taki, T
    Adachi, M
    Konishi, T
    Higashiyama, M
    Miyake, M
    ONCOGENE, 1998, 16 (19) : 2469 - 2477
  • [30] Investigation of HER2 overexpression in non-small cell lung cancer
    Ugocsai, K
    Mándoky, L
    Tiszlavicz, L
    Molnár, J
    ANTICANCER RESEARCH, 2005, 25 (04) : 3061 - 3066
12345